GLORIA WRIGHT: Open Payments
NPI 1558881169 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 16 payments from 7 companies in 2025. Trend: 2023 $521 · 2024 $1,393 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $174 |
| Alkermes, Inc. | 2 | $157 |
| ABIOMED | 1 | $149 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| ABBVIE INC. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: COBENFY, Auvelity, LYBALVI, VRAYLAR, CAPLYTA, ARISTADA, REXULTI.
Industry payments across TX — which companies pay providers there.
